Literature DB >> 34166717

Commissioning and clinical implementation of an Autoencoder based Classification-Regression model for VMAT patient-specific QA in a multi-institution scenario.

Ruijie Yang1, Xueying Yang2, Le Wang3, Dingjie Li4, Yuexin Guo5, Ying Li6, Yumin Guan7, Xiangyang Wu8, Shouping Xu9, Shuming Zhang10, Maria F Chan11, Lisheng Geng12, Jing Sui13.   

Abstract

BACKGROUND AND
PURPOSE: To commission and implement an Autoencoder based Classification-Regression (ACLR) model for VMAT patient-specific quality assurance (PSQA) in a multi-institution scenario.
MATERIALS AND METHODS: 1835 VMAT plans from seven institutions were collected for the ACLR model commissioning and multi-institutional validation. We established three scenarios to validate the gamma passing rates (GPRs) prediction and classification accuracy with the ACLR model for different delivery equipment, QA devices, and treatment planning systems (TPS). The prediction performance of the ACLR model was evaluated using mean absolute error (MAE) and root mean square error (RMSE). The classification performance was evaluated using sensitivity and specificity. An independent end-to-end test (E2E) and routine QA of the ACLR model were performed to validate the clinical use of the model.
RESULTS: For multi-institution validations, the MAEs were 1.30-2.80% and 2.42-4.60% at 3%/3 mm and 3%/2 mm, respectively, and RMSEs were 1.55-2.98% and 2.83-4.95% at 3%/3 mm and 3%/2 mm, respectively, with different delivery equipment, QA devices, and TPS, while the sensitivity was 90% and specificity was 70.1% at 3%/2 mm. For the E2E, the deviations between the predicted and measured results were within 3%, and the model passed the consistency check for clinical implementation. The predicted results of the model were the same in daily QA, while the deviations between the repeated monthly measured GPRs were all within 2%.
CONCLUSIONS: The performance of the ACLR model in multi-institution scenarios was validated on a large scale. Routine QA of the ACLR model was established and the model could be used for VMAT PSQA clinically.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical implementation; Commissioning; Machine learning; Multi-institution validation; VMAT patient-specific QA

Mesh:

Year:  2021        PMID: 34166717      PMCID: PMC9388201          DOI: 10.1016/j.radonc.2021.06.024

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.901


  27 in total

1.  Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.

Authors:  Giorgia Nicolini; Sarbani Ghosh-Laskar; Shyam Kishore Shrivastava; Sushovan Banerjee; Suresh Chaudhary; Jai Prakash Agarwal; Anusheel Munshi; Alessandro Clivio; Antonella Fogliata; Pietro Mancosu; Eugenio Vanetti; Luca Cozzi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-02       Impact factor: 7.038

2.  Task Group 142 report: quality assurance of medical accelerators.

Authors:  Eric E Klein; Joseph Hanley; John Bayouth; Fang-Fang Yin; William Simon; Sean Dresser; Christopher Serago; Francisco Aguirre; Lijun Ma; Bijan Arjomandy; Chihray Liu; Carlos Sandin; Todd Holmes
Journal:  Med Phys       Date:  2009-09       Impact factor: 4.071

Review 3.  Radiation Therapy Quality Assurance Tasks and Tools: The Many Roles of Machine Learning.

Authors:  Alan M Kalet; Samuel M H Luk; Mark H Phillips
Journal:  Med Phys       Date:  2019-03-04       Impact factor: 4.071

4.  Predicting VMAT patient-specific QA results using a support vector classifier trained on treatment plan characteristics and linac QC metrics.

Authors:  Dal A Granville; Justin G Sutherland; Jason G Belec; Daniel J La Russa
Journal:  Phys Med Biol       Date:  2019-04-29       Impact factor: 3.609

Review 5.  Overview of artificial intelligence-based applications in radiotherapy: Recommendations for implementation and quality assurance.

Authors:  Liesbeth Vandewinckele; Michaël Claessens; Anna Dinkla; Charlotte Brouwer; Wouter Crijns; Dirk Verellen; Wouter van Elmpt
Journal:  Radiother Oncol       Date:  2020-09-10       Impact factor: 6.280

6.  Error detection using a convolutional neural network with dose difference maps in patient-specific quality assurance for volumetric modulated arc therapy.

Authors:  Yuto Kimura; Noriyuki Kadoya; Seiji Tomori; Yohei Oku; Keiichi Jingu
Journal:  Phys Med       Date:  2020-04-21       Impact factor: 2.685

7.  Predicting gamma passing rates for portal dosimetry-based IMRT QA using machine learning.

Authors:  Dao Lam; Xizhe Zhang; Harold Li; Yang Deshan; Brayden Schott; Tianyu Zhao; Weixiong Zhang; Sasa Mutic; Baozhou Sun
Journal:  Med Phys       Date:  2019-08-27       Impact factor: 4.071

8.  Deep learning for patient-specific quality assurance: Identifying errors in radiotherapy delivery by radiomic analysis of gamma images with convolutional neural networks.

Authors:  Matthew J Nyflot; Phawis Thammasorn; Landon S Wootton; Eric C Ford; W Art Chaovalitwongse
Journal:  Med Phys       Date:  2018-12-28       Impact factor: 4.071

9.  IMRT QA using machine learning: A multi-institutional validation.

Authors:  Gilmer Valdes; Maria F Chan; Seng Boh Lim; Ryan Scheuermann; Joseph O Deasy; Timothy D Solberg
Journal:  J Appl Clin Med Phys       Date:  2017-08-17       Impact factor: 2.102

10.  AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations - Megavoltage Photon and Electron Beams.

Authors:  Jennifer B Smilowitz; Indra J Das; Vladimir Feygelman; Benedick A Fraass; Stephen F Kry; Ingrid R Marshall; Dimitris N Mihailidis; Zoubir Ouhib; Timothy Ritter; Michael G Snyder; Lynne Fairobent
Journal:  J Appl Clin Med Phys       Date:  2015-09-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.